综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

National

Regional

Taiwan, HK, Macao

Special Coverage

Focus

Society

Profiles

7.3M doses of H1N1 vaccine ordered for home use

(Xinhua)
Updated: 2009-09-04 20:31

BEIJING: The Chinese government Friday ordered 7.3 million doses of A(H1N1) flu vaccine from domestic pharmaceutical companies Sinovac and Hualan, the first firms to receive production licenses.

The Ministry of Industry and Information Technology (MIIT) ordered 3.3 million 15-microgram doses of vaccine from Sinovac and 4 million from Hualan Biological Engineering Inc. They are required to fill the orders within ten days, the two companies said Friday.

The vaccines will be reserved by the State instead of going on general sale across the country.

Full Coverage:  Flu Pandemic Outbreak Related readings:  China approves one-dose homegrown H1N1 flu vaccine  Another A(H1N1) patient dies in Hong Kong  A/H1N1 flu vaccine put into production  Green light for 2nd H1N1 flu vaccine  China's H1N1 flu vaccine passes muster

The State Food and Drug Administration (SFDA) issued the first license in the world for Sinovac vaccine Panflu 1 on Thursday, and issued the license for Hualan's vaccine on Friday. Both have passed SFDA experts' evaluation.

Panflu 1 can be given safely to people aged from three to 60 years old in a single shot, while Hualan's vaccine is suitable for all aged over three, according to evaluation reports.

Sinovac said it had the capacity to produce 5 million doses of vaccine before October 1, and 20 to 30 million doses a year. Hualan said it could produce 13 million doses before October 1.

MIIT ordered the vaccine following Ministry of Health recommendation, and the cost will be paid by the Ministry of Finance.

Health Minister Chen Zhu said in August that China would be able to produce enough A(H1N1) flu vaccine for 65 million people by the end of the year.